Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZXDA is a member of the zinc finger, X-linked, duplicated (ZXD) family of proteins and shares significant sequence homology with the related proteins ZXDC and ZXDB[1][2]. ZXDA contains ten C2H2-type zinc finger domains (involved in protein-protein and potentially DNA interactions) and a C-terminal transcriptional activation domain[2]. ZXDA, often forming a hetero-complex with ZXDC, is required for the transcriptional activation of MHC II genes, acting through interaction with the class II trans-activator (CIITA) protein[1][2][4]. Its role is vital for immune function, particularly antigen presentation by MHC II; ZXDA’s depletion impairs CIITA-mediated activation of MHC II genes[1][2][4]. ZXDA is thus best classified as a transcription factor involved in immune regulation, not as an enzyme, receptor, or transporter, and currently has no established direct pharmacological targeting or biomarker utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger X-linked duplicated protein A (ZXDA).